FDA.reportPublic FDA data

naphazoline hydrochloride 0.5 MG/ML Nasal Solution

RxCUI
1046602
RxNorm name
naphazoline hydrochloride 0.5 MG/ML Nasal Solution
Display name
Naphazoline (Nasal)
Full name
naphazoline hydrochloride 0.5 MG/ML Nasal Solution
Term type
SCD
Status
Active
Strength
0.05%
Dose form
Sol
Route
Nasal
Updated
2026-06-15 06:59:35

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122010
Active start
122010
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
naphazoline hydrochloride0.5 MG / 1 MLnaphazolinenaphazoline hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Nasal Solution316962

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
naphazoline7247

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRnaphazoline hydrochloride 0.5 MG/ML Nasal SolutionNAMES
RxNorm Namenaphazoline hydrochloride 0.5 MG/ML Nasal SolutionNAMES
RxNorm Synonymnaphazoline hydrochloride 0.05 % Nasal SolutionNAMES
TTYSCDATTRIBUTES
SPL_SET_ID30cade3d-208f-8594-e063-6394a90ad2a0CODES
SPL_SET_ID4d4043f8-5ed3-4027-beb6-687db1308202CODES
RxCUI1046602CODES
MMSL_CODECD6057CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
12539-146-0212539-146NAFASOLINA Naphazoline hydrochlorideDoral Pharmamedics Inc DBA AG Marin PharmaceuticalsM012
49873-057-0149873-057Nazal Naphazoline hydrochlorideSato Pharmaceutical Co., Ltd.M012

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
M01212539-146NAFASOLINA Naphazoline hydrochlorideOTC MONOGRAPH DRUGDoral Pharmamedics Inc DBA AG Marin Pharmaceuticals

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
12539014601rxnav_ndcsyes
12539014602rxnav_ndcsyes
49873005701rxnav_ndcsyes
00083651158rxnav_historical
00083651176rxnav_historical
00083661158rxnav_historical_indirect
00083662071rxnav_historical_indirect
00083662076rxnav_historical_indirect
63736066207rxnav_historical_indirect

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4d4043f8-5ed3-4027-beb6-687db1308202naphazoline HCl 0.05 % Nasal SolutionPSN7Nazal20231206
4d4043f8-5ed3-4027-beb6-687db1308202naphazoline hydrochloride 0.05 % Nasal SolutionSY7Nazal20231206
4d4043f8-5ed3-4027-beb6-687db1308202naphazoline hydrochloride 0.5 MG/ML Nasal SolutionSCD7Nazal20231206
30cade3d-208f-8594-e063-6394a90ad2a0naphazoline HCl 0.05 % Nasal SolutionPSN2Naphazoline hydrochloride 0.05%20251218
30cade3d-208f-8594-e063-6394a90ad2a0naphazoline hydrochloride 0.5 MG/ML Nasal SolutionSCD2Naphazoline hydrochloride 0.05%20251218
30cade3d-208f-8594-e063-6394a90ad2a0naphazoline hydrochloride 0.05 % Nasal SolutionSY2Naphazoline hydrochloride 0.05%20251218

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
30cade3d-208f-8594-e063-6394a90ad2a0Naphazoline hydrochloride 0.05%Doral Pharmamedics Inc DBA AG Marin Pharmaceuticals | DEXTRUM LABORATORIES INC.20251218
4d4043f8-5ed3-4027-beb6-687db1308202NazalSato Pharmaceutical Co., Ltd.20231206

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCS01GASympathomimetics used as decongestantsATC1-4naphazoline
ATCR01ABSympathomimetics, combinations excl. corticosteroidsATC1-4naphazoline
ATCR01AASympathomimetics, plainATC1-4naphazoline
MEDRTD009278NaphazolineCHEMhas_ingredientnaphazoline
MEDRTD009278NaphazolineCHEMhas_ingredientnaphazoline hydrochloride
MEDRTD004342Drug HypersensitivityDISEASEci_withnaphazoline
MEDRTD004342Drug HypersensitivityDISEASEci_withnaphazoline hydrochloride
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withnaphazoline hydrochloride
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withnaphazoline
MEDRTD006940HyperemiaDISEASEmay_treatnaphazoline
MEDRTD006940HyperemiaDISEASEmay_treatnaphazoline hydrochloride
MEDRTD012220RhinitisDISEASEmay_treatnaphazoline hydrochloride
MEDRTD012220RhinitisDISEASEmay_treatnaphazoline
MEDRTD012852SinusitisDISEASEmay_treatnaphazoline
MEDRTD012852SinusitisDISEASEmay_treatnaphazoline hydrochloride
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moanaphazoline
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moanaphazoline hydrochloride
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_penaphazoline
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_penaphazoline hydrochloride
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_penaphazoline
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_penaphazoline hydrochloride

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.5 MG/ML
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSCD
CODESMMSL_CODECD6057
CODESRxCUI1046602
CODESSPL_SET_ID30cade3d-208f-8594-e063-6394a90ad2a0
CODESSPL_SET_ID4d4043f8-5ed3-4027-beb6-687db1308202
CODESVUID4005501
NAMESPrescribable Synonymnaphazoline HCl 0.05 % Nasal Solution
NAMESRXNAV_STRnaphazoline hydrochloride 0.5 MG/ML Nasal Solution
NAMESRxNorm Namenaphazoline hydrochloride 0.5 MG/ML Nasal Solution
NAMESRxNorm Synonymnaphazoline hydrochloride 0.05 % Nasal Solution
SOURCESSourceMetathesaurus FDA Structured Product Labels